Silexion Therapeutics Corp (SLXNW) Capital expenditures 2023–2025
Silexion Therapeutics Corp (SLXNW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$9,000FY2025 · since FY2023: $12,000 → $9,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9,000 | -59.1% |
| FY2024 | $22,000 | +83.3% |
| FY2023 | $12,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More SLXNW financial trends
SLXNW RevenueSLXNW Net incomeSLXNW Net marginSLXNW Gross profitSLXNW Gross marginSLXNW Operating incomeSLXNW Operating marginSLXNW Operating cash flowSLXNW Free cash flowSLXNW Return on equitySLXNW Stock buybacksSLXNW Dividends paidSLXNW Total assetsSLXNW Total liabilitiesSLXNW Shareholders’ equitySLXNW overview →